A study investigated the effects of Cycloastragenol and Astragaloside IV, compounds derived from the herb Astragalus membranaceus, on nucleus pulposus cells exposed to high glucose conditions. The findings revealed that these compounds activated telomerase, reduced cellular senescence and apoptosis, and improved cell viability, suggesting their potential therapeutic role in managing diabetes-induced intervertebral disc degeneration.